A Structure-Activity Relationship Study of Bis-Benzamides as Inhibitors of Androgen Receptor-Coactivator Interaction

Tae Kyung Lee, Preethi Ravindranathan, Rajni Sonavane, Ganesh Raj, Jung-Mo Ahn

Research output: Contribution to journalArticle

Abstract

The interaction between androgen receptor (AR) and coactivator proteins plays a critical role in AR-mediated prostate cancer (PCa) cell growth, thus its inhibition is emerging as a promising strategy for PCa treatment. To develop potent inhibitors of the AR-coactivator interaction, we have designed and synthesized a series of bis-benzamides by modifying functional groups at the N/C-terminus and side chains. A structure-activity relationship study showed that the nitro group at the N-terminus of the bis-benzamide is essential for its biological activity while the C-terminus can have either a methyl ester or a primary carboxamide. Surveying the side chains with various alkyl groups led to the identification of a potent compound 14d that exhibited antiproliferative activity (IC50 value of 16 nM) on PCa cells. In addition, biochemical studies showed that 14d exerts its anticancer activity by inhibiting the AR-PELP1 interaction and AR transactivation.

Original languageEnglish (US)
JournalMolecules (Basel, Switzerland)
Volume24
Issue number15
DOIs
StatePublished - Jul 31 2019

Fingerprint

Benzamides
Androgen Receptors
Structure-Activity Relationship
inhibitors
Prostatic Neoplasms
cancer
interactions
Oncology
Surveying
Cell growth
activity (biology)
Bioactivity
Functional groups
Transcriptional Activation
Inhibitory Concentration 50
esters
emerging
Esters
proteins
Growth

Keywords

  • androgen receptor
  • bis-benzamide scaffold
  • coactivator PELP1
  • prostate cancer
  • protein–protein interaction
  • α-helix mimetics

ASJC Scopus subject areas

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Cite this

A Structure-Activity Relationship Study of Bis-Benzamides as Inhibitors of Androgen Receptor-Coactivator Interaction. / Lee, Tae Kyung; Ravindranathan, Preethi; Sonavane, Rajni; Raj, Ganesh; Ahn, Jung-Mo.

In: Molecules (Basel, Switzerland), Vol. 24, No. 15, 31.07.2019.

Research output: Contribution to journalArticle

@article{05a8e06095b745cd96037e4e2337278a,
title = "A Structure-Activity Relationship Study of Bis-Benzamides as Inhibitors of Androgen Receptor-Coactivator Interaction",
abstract = "The interaction between androgen receptor (AR) and coactivator proteins plays a critical role in AR-mediated prostate cancer (PCa) cell growth, thus its inhibition is emerging as a promising strategy for PCa treatment. To develop potent inhibitors of the AR-coactivator interaction, we have designed and synthesized a series of bis-benzamides by modifying functional groups at the N/C-terminus and side chains. A structure-activity relationship study showed that the nitro group at the N-terminus of the bis-benzamide is essential for its biological activity while the C-terminus can have either a methyl ester or a primary carboxamide. Surveying the side chains with various alkyl groups led to the identification of a potent compound 14d that exhibited antiproliferative activity (IC50 value of 16 nM) on PCa cells. In addition, biochemical studies showed that 14d exerts its anticancer activity by inhibiting the AR-PELP1 interaction and AR transactivation.",
keywords = "androgen receptor, bis-benzamide scaffold, coactivator PELP1, prostate cancer, protein–protein interaction, α-helix mimetics",
author = "Lee, {Tae Kyung} and Preethi Ravindranathan and Rajni Sonavane and Ganesh Raj and Jung-Mo Ahn",
year = "2019",
month = "7",
day = "31",
doi = "10.3390/molecules24152783",
language = "English (US)",
volume = "24",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "15",

}

TY - JOUR

T1 - A Structure-Activity Relationship Study of Bis-Benzamides as Inhibitors of Androgen Receptor-Coactivator Interaction

AU - Lee, Tae Kyung

AU - Ravindranathan, Preethi

AU - Sonavane, Rajni

AU - Raj, Ganesh

AU - Ahn, Jung-Mo

PY - 2019/7/31

Y1 - 2019/7/31

N2 - The interaction between androgen receptor (AR) and coactivator proteins plays a critical role in AR-mediated prostate cancer (PCa) cell growth, thus its inhibition is emerging as a promising strategy for PCa treatment. To develop potent inhibitors of the AR-coactivator interaction, we have designed and synthesized a series of bis-benzamides by modifying functional groups at the N/C-terminus and side chains. A structure-activity relationship study showed that the nitro group at the N-terminus of the bis-benzamide is essential for its biological activity while the C-terminus can have either a methyl ester or a primary carboxamide. Surveying the side chains with various alkyl groups led to the identification of a potent compound 14d that exhibited antiproliferative activity (IC50 value of 16 nM) on PCa cells. In addition, biochemical studies showed that 14d exerts its anticancer activity by inhibiting the AR-PELP1 interaction and AR transactivation.

AB - The interaction between androgen receptor (AR) and coactivator proteins plays a critical role in AR-mediated prostate cancer (PCa) cell growth, thus its inhibition is emerging as a promising strategy for PCa treatment. To develop potent inhibitors of the AR-coactivator interaction, we have designed and synthesized a series of bis-benzamides by modifying functional groups at the N/C-terminus and side chains. A structure-activity relationship study showed that the nitro group at the N-terminus of the bis-benzamide is essential for its biological activity while the C-terminus can have either a methyl ester or a primary carboxamide. Surveying the side chains with various alkyl groups led to the identification of a potent compound 14d that exhibited antiproliferative activity (IC50 value of 16 nM) on PCa cells. In addition, biochemical studies showed that 14d exerts its anticancer activity by inhibiting the AR-PELP1 interaction and AR transactivation.

KW - androgen receptor

KW - bis-benzamide scaffold

KW - coactivator PELP1

KW - prostate cancer

KW - protein–protein interaction

KW - α-helix mimetics

UR - http://www.scopus.com/inward/record.url?scp=85070987563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070987563&partnerID=8YFLogxK

U2 - 10.3390/molecules24152783

DO - 10.3390/molecules24152783

M3 - Article

VL - 24

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 15

ER -